Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Drops By 8.2%

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 15,080,000 shares, a decrease of 8.2% from the January 15th total of 16,420,000 shares. Based on an average trading volume of 6,160,000 shares, the days-to-cover ratio is presently 2.4 days.

Wall Street Analyst Weigh In

Separately, Craig Hallum assumed coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock.

Get Our Latest Analysis on CLOV

Institutional Investors Weigh In On Clover Health Investments

A number of institutional investors and hedge funds have recently bought and sold shares of CLOV. Concurrent Investment Advisors LLC purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at about $28,000. Sigma Planning Corp purchased a new stake in Clover Health Investments in the third quarter valued at approximately $29,000. Parallax Volatility Advisers L.P. acquired a new stake in shares of Clover Health Investments in the third quarter valued at approximately $38,000. Realta Investment Advisors purchased a new position in shares of Clover Health Investments during the third quarter worth approximately $44,000. Finally, Forum Financial Management LP increased its holdings in shares of Clover Health Investments by 33.8% in the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after acquiring an additional 4,061 shares during the period. 19.77% of the stock is owned by hedge funds and other institutional investors.

Clover Health Investments Trading Down 1.0 %

Shares of Clover Health Investments stock opened at $4.42 on Wednesday. The company has a fifty day simple moving average of $3.85 and a 200-day simple moving average of $3.46. The stock has a market cap of $2.21 billion, a price-to-earnings ratio of -22.07 and a beta of 1.99. Clover Health Investments has a 12-month low of $0.61 and a 12-month high of $4.87.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Read More

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.